Patents by Inventor Jacob GALSON

Jacob GALSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYPEPTIDES ENCODING ANTIBODIES BINDING TO SARS-COV-2 SPIKE PROTEIN
    Publication number: 20230192821
    Abstract: There is provided inter alia a polypeptide comprising a CDRH1 sequence comprising or consisting of a sequence sharing 80% or greater sequence identity with a CDRH1 sequence as shown in Table 1 and/or a CDRH2 sequence comprising or consisting of a sequence sharing 80% or greater sequence identity with a CDRH2 sequence as shown in Table 1 and/or a CDRH3 sequence comprising or consisting of a sequence sharing 80% or greater sequence identity with a CDRH3 sequence as shown in Table 1.
    Type: Application
    Filed: May 20, 2021
    Publication date: June 22, 2023
    Applicants: Alchemab Therapeutics Ltd, BARTS HEALTH NHS TRUST
    Inventors: Jane Osbourn, Ralph Minter, Jacob Galson
  • ANTIBODIES TO ICOS
    Publication number: 20200317786
    Abstract: Antibodies that bind ICOS (Inducible T cell Co-Stimulator). Therapeutic use of anti-ICOS antibodies for modulating the ratio between regulatory T cells and effector T cells, to stimulate the immune system of patients, including use in treating cancers. Combinations of anti-ICOS antibodies and other drugs for immunooncology.
    Type: Application
    Filed: December 19, 2018
    Publication date: October 8, 2020
    Inventors: Aksana LABOKHA, Nahida PARVEEN, Jacob GALSON, Richard Charles Alfred SAINSON, Stephen John ARKINSTALL